GLP-1 medications can sometimes affect sleep patterns for certain individuals
However, if intolerable side effects such as nausea or vomiting occur, the treatment is discontinued
By achieving unprecedented efficacy in weight loss, glycemic control, and cardiovascular outcomes, semaglutide demonstrated the full potential of GLP-1 receptor activation while highlighting the limitations of monoreceptor therapynamely, variable interindividual response, plateauing efficacy, and dose-related GI intolerance
Theyre both long-term medicationspeople typically take Mounjaro and Ozempic for at least 12 weeks and up to a year or longer
If you are struggling with hypoglycemia after starting semaglutide, talk with your doctor
Research in the International Journal of Obesity found that participants receiving both probiotics and GLP-1 therapy experienced greater reductions in body weight and fat mass compared to those on GLP-1 therapy alone